Business Context and Reporting Period
Company: Smith Micro Software, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 11, 2025
Event: Entry into Material Definitive Agreements involving secured promissory notes and unregistered common stock purchase warrants with key executives.
Key Financial Metrics and Transaction Details
This filing reports a specific financing transaction rather than periodic financial performance metrics (revenue, profit, cash flow). The following financial terms apply to the transaction:
- Total Gross Proceeds: Approximately $933,000 (comprised of $833,000 from the Smith Living Trust and $100,000 from Timothy C. Huffmyer).
- Loan Principal Received: Approximately $794,736 ($709,706 from Smith; $85,030 from Huffmyer).
- Warrant Proceeds: Approximately $138,263 ($123,293 from Smith; $14,970 from Huffmyer).
- Interest Rate: 15.0% per annum on the Notes.
- Maturity Date: On or before March 31, 2026.
- Collateral: Notes are secured by the Company's accounts receivable and certain other assets.
- Warrant Terms: Exercisable after 6 months; expire 5 years from initial exercise date; exercise price is the greater of the Market Price on the agreement date or issuance date.
Material Changes and Transaction Structure
The Company entered into Note Purchase Agreements with William W. Smith, Jr. (Chairman, President, CEO) via the Smith Living Trust and Timothy C. Huffmyer (COO, CFO). The transaction structure includes:
- Secured Debt: The Company received loans capped at $715,000 from Smith and $90,000 from Huffmyer.
- Equity Kicker: Each Note is accompanied by unregistered warrants. The number of warrant shares equals the principal amount divided by the Market Price on the issuance date.
- Anti-Dilution Protection: Warrants contain a "full-ratchet" anti-dilution adjustment. If the Company issues stock below the warrant exercise price, the exercise price will be adjusted downward, and the share count adjusted proportionately.
- Regulatory Approval: No anti-dilution adjustments will occur until the Company receives stockholder approval in accordance with Nasdaq Listing Rule 5635. The Company anticipates seeking this approval at its next annual meeting.
Guidance, Outlook, and Risks
Use of Proceeds: The Company expects to use net proceeds for working capital and general corporate purposes.
Management Commentary: The transactions were approved by an independent committee of the Board of Directors and the Audit Committee.
Risks and Contingencies:
- Dilution Risk: The full-ratchet anti-dilution provision could significantly increase the number of shares issuable upon exercise if the stock price declines.
- Debt Obligation: The Company has a direct financial obligation to repay the principal plus 15% interest by March 31, 2026.
- Forward-Looking Statements: The filing contains forward-looking statements regarding future plans and expectations, which are subject to risks and uncertainties that may cause actual results to differ materially.
Investor Verification Checklist
- Verify the exact number of Warrant Shares issued based on the Market Price on the issuance date.
- Confirm the status of the stockholder vote required for the "full-ratchet" anti-dilution adjustment to become effective.
- Review the Company's current accounts receivable balance to assess the sufficiency of collateral for the secured notes.
- Monitor the Company's cash flow to ensure ability to service the 15% interest and principal repayment by March 31, 2026.
- Check for any subsequent filings regarding the registration statement for the resale of Warrant Shares.